• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study.

作者信息

Bratfos O, Haug J O

出版信息

Acta Psychiatr Scand. 1979 Jul;60(1):1-9. doi: 10.1111/j.1600-0447.1979.tb00259.x.

DOI:10.1111/j.1600-0447.1979.tb00259.x
PMID:382750
Abstract

In a material of 71 patients admitted because of acute or chronic psychoses, 32 were treated with sulpiride (up to 1,800 mg per day) and 39 with chlorpromazine (up to 675 mg). Duration of treatment was from 4 to 8 weeks. The effect of the two preparations was very similar as were the type and frequency of side effects, except that sulpiride did not cause sunrash.

摘要

相似文献

1
Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study.
Acta Psychiatr Scand. 1979 Jul;60(1):1-9. doi: 10.1111/j.1600-0447.1979.tb00259.x.
2
Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.舒必利和氯丙嗪对精神分裂症患者自闭症及阳性精神病性症状的影响——与药物浓度的关系
Psychopharmacology (Berl). 1985;85(1):8-13. doi: 10.1007/BF00427315.
3
Clinical evaluation of sulpiride in schizophrenic patients--a double-blind comparison with chlorpromazine.舒必利治疗精神分裂症患者的临床评估——与氯丙嗪的双盲对照研究。
Acta Psychiatr Scand Suppl. 1984;311:7-30. doi: 10.1111/j.1600-0447.1984.tb06856.x.
4
Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.舒必利或氯丙嗪治疗的精神分裂症患者血清与脑脊液中药物浓度、临床疗效及单胺能变量之间的关系。
Acta Psychiatr Scand Suppl. 1984;311:49-74. doi: 10.1111/j.1600-0447.1984.tb06859.x.
5
[Three antipsychotic drugs in the treatment of schizophrenia--a controlled and double-blind study].三种抗精神病药物治疗精神分裂症——一项对照双盲研究
Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1988 Oct;21(5):277-80, 318-9.
6
Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.
Psychopharmacology (Berl). 1984;84(2):237-41. doi: 10.1007/BF00427452.
7
The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.
J Clin Pharmacol J New Drugs. 1970 Mar-Apr;10(2):126-31. doi: 10.1177/009127007001000208.
8
[Effect of neuroleptic therapy on the structure of an episode in acute alcoholic psychoses].[抗精神病药物治疗对急性酒精性精神病发作结构的影响]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1987;87(6):894-7.
9
[Oxyhemometric studies of patients with schizophrenia and reactive psychoses while treating them with neuroleptics].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1968;68(6):906-13.
10
A double-blind comparison of sulpiride with chlorpromazine in chronic schizophrenia.舒必利与氯丙嗪治疗慢性精神分裂症的双盲对照研究
J Clin Pharmacol New Drugs. 1972 May-Jun;12(5):221-9. doi: 10.1002/j.1552-4604.1972.tb00166.x.

引用本文的文献

1
Sulpiride versus placebo for schizophrenia.舒必利与安慰剂治疗精神分裂症的对比
Cochrane Database Syst Rev. 2014 Apr 11;2014(4):CD007811. doi: 10.1002/14651858.CD007811.pub2.
2
Detecting potential adverse reactions of sulpiride in schizophrenic patients by prescription sequence symmetry analysis.通过处方序列对称性分析检测精神分裂症患者中舒必利的潜在不良反应。
PLoS One. 2014 Feb 27;9(2):e89795. doi: 10.1371/journal.pone.0089795. eCollection 2014.
3
Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up.
帕金森病丘脑底核刺激术后的功能改善:一项随访12至24个月的非等效对照研究。
J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):769-74. doi: 10.1136/jnnp.2004.047001.
4
Sulpiride for schizophrenia.舒必利治疗精神分裂症。
Cochrane Database Syst Rev. 2000;1999(2):CD001162. doi: 10.1002/14651858.CD001162.
5
A risk-benefit assessment of sulpiride in the treatment of schizophrenia.
Drug Saf. 1996 May;14(5):288-98. doi: 10.2165/00002018-199614050-00003.
6
Drug treatment of resistant schizophrenia. Limitations and recommendations.难治性精神分裂症的药物治疗。局限性与建议。
Drugs. 1993 Mar;45(3):374-83. doi: 10.2165/00003495-199345030-00006.
7
BRL 20596, a novel anilide with central dopamine antagonist activity.BRL 20596,一种具有中枢多巴胺拮抗活性的新型酰苯胺。
Psychopharmacology (Berl). 1986;89(2):208-15. doi: 10.1007/BF00310631.